SEC Tracker
Get the app

Seres Therapeutics MCRB

Seres Therapeutics appoints Marella Thorell

Form
8-K
Filed
Importance
Routine
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Seres Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Oncolytics Biotech ONCY public float $72M, Jun 30, 2025
  2. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025
  3. Macrogenics MGNX public float $74M, Jun 30, 2025
  4. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
  5. Oramed Pharmaceuticals ORMP public float $78M, Jun 30, 2025